glp-1 news november 3 2025 Weight-Loss Drug Demonstration Begins July 2026 The 2025 medical news cycle

GHK-Cu accelerates anti-inflammatory activity and repairs DNA damage

The long-acting strategies of GLP-1 drugs (amino acid substitutions, fatty acid side chain modifications, Fc fusion proteins, PEGylation) described in the article are only a small part of the current long-acting strategies, which have actually been applied to other protein-peptide drugs as early as

Ironsulfur cluster protein CDGSH iron sulfur domain (CISD) 1, a mitochondrial outer membrane protein, regulates VDAC in a redox-dependent manner in cells and closes mitochondrial pores to prevent iron accumulation in the mitochondria [49]

Don't be discouraged by a plateau